ConductScience.org, home

Paper396335

Opsonic specificity of human antibody to the type III polysaccharide of group B Streptococcus.

Edwards MS and 2 others. J Infect Dis, 1979. Cited by 93 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Opsonic specificity of human antibody to the type III polysaccharide of group B Streptococcus. Papers, record 396335. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/396335

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Opsonic specificity of human antibody to the type III polysaccharide of group B Streptococcus.
PubMed
Journal
J Infect Dis
PubMed
Year
1979
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
93
iCite
Relative citation ratio, by iCite
3.24
iCite
Revised in PubMed
2019-05-09
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Edwards MSM S
2Baker CJC J
3Kasper DLD L

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibody SpecificityMajor topic
Opsonin ProteinsMajor topic
Polysaccharides, BacterialMajor topic
Streptococcus agalactiaeMajor topic
Absorption
Bacterial Vaccines
Blood Bactericidal Activity
Humans
Neutrophils
Oxygen Consumption
Phagocytosis

Source PubMed

Cited by35

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 93 citations.

PMIDTitleJournalYearIn PapersSource
38,006,035Development of A Standardized Opsonophagocytosis Killing Assay for Group B Streptococcus and Assessment in an Interlaboratory Study.Vaccines (Basel)2023https://conductscience.org/library/papers/38006035PubMed
28,449,969Association between functional antibody against Group B Streptococcus and maternal and infant colonization in a Gambian cohort.Vaccine2017https://conductscience.org/library/papers/28449969PubMed
28,162,823Mucosal vaccination promotes clearance of Streptococcus agalactiae vaginal colonization.Vaccine2017https://conductscience.org/library/papers/28162823PubMed
27,803,803Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries.F1000Res2016https://conductscience.org/library/papers/27803803PubMed
26,608,922The Group B Streptococcus-Secreted Protein CIP Interacts with C4, Preventing C3b Deposition via the Lectin and Classical Complement Pathways.J Immunol2016https://conductscience.org/library/papers/26608922PubMed
25,589,553Antibody-mediated complement C3b/iC3b binding to group B Streptococcus in paired mother and baby serum samples in a refugee population on the Thailand-Myanmar border.Clin Vaccine Immunol2015https://conductscience.org/library/papers/25589553PubMed
24,554,752Characterization of invasive group B streptococcus strains from the greater Toronto area, Canada.J Clin Microbiol2014https://conductscience.org/library/papers/24554752PubMed
19,490,960Group B streptococcal conjugate vaccines elicit functional antibodies independent of strain O-acetylation.Vaccine2009https://conductscience.org/library/papers/19490960PubMed
18,155,812Alpha C protein-specific immunity in humans with group B streptococcal colonization and invasive disease.Vaccine2008https://conductscience.org/library/papers/18155812PubMed
17,938,215
L-Ficolin/mannose-binding lectin-associated serine protease complexes bind to group B streptococci primarily through N-acetylneuraminic acid of capsular polysaccharide and activate the complement pathway.
Infect Immun2008https://conductscience.org/library/papers/17938215PubMed
10,992,487Lectin site interaction with capsular polysaccharide mediates nonimmune phagocytosis of type III group B streptococci.Infect Immun2000https://conductscience.org/library/papers/10992487PubMed
10,722,601Nonopsonic binding of type III Group B Streptococci to human neutrophils induces interleukin-8 release mediated by the p38 mitogen-activated protein kinase pathway.Infect Immun2000https://conductscience.org/library/papers/10722601PubMed
9,826,364Estimation of group B streptococcus type III polysaccharide-specific antibody concentrations in human sera is antigen dependent.Infect Immun1998https://conductscience.org/library/papers/9826364PubMed
9,665,980Epidemiology of group B streptococcal disease in the United States: shifting paradigms.Clin Microbiol Rev1998https://conductscience.org/library/papers/9665980PubMed
9,536,123Group B streptococci persist inside macrophages.Immunology1998https://conductscience.org/library/papers/9536123PubMed
9,529,079Characterization of anticapsular monoclonal antibodies that regulate activation of the complement system by the Cryptococcus neoformans capsule.Infect Immun1998https://conductscience.org/library/papers/9529079PubMed
9,418,188Contribution of antibody to neutrophil-mediated killing of Enterococcus faecalis.J Clin Immunol1997https://conductscience.org/library/papers/9418188PubMed
8,698,468Entry and intracellular survival of group B streptococci in J774 macrophages.Infect Immun1996https://conductscience.org/library/papers/8698468PubMed
8,514,389Capsular polysaccharide regulates neutrophil complement receptor interactions with type III group B streptococci.Infect Immun1993https://conductscience.org/library/papers/8514389PubMed
8,454,344Neutrophil Fc receptor participation in phagocytosis of type III group B streptococci.Infect Immun1993https://conductscience.org/library/papers/8454344PubMed

See all 35 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/396335

GET https://conductscience.org/api/papers/v1/396335/cited_by?page=2